765302-47-4

Basic information

• Product Name: ethyl 2-(3-methoxy-4-methylphenyl)acetate
• Synonyms: ethyl 2-(3-methoxy-4-methylphenyl)acetate
• CAS NO: 765302-47-4
• Molecular Weight: 208.257
• Mol File: 765302-47-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: ethyl 2-(3-methoxy-4-methylphenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-(3-methoxy-4-methylphenyl)acetate(765302-47-4)
• EPA Substance Registry System: ethyl 2-(3-methoxy-4-methylphenyl)acetate(765302-47-4)

Safety Data

• Hazardous Substances Data: 765302-47-4(Hazardous Substances Data)

Upstream product

• 64829-31-8 2-(3-methoxy-4-methylphenyl)acetonitrile 
• 64-17-5 ethanol 
• 100861-38-9 (3-methoxy-4-methylphenyl)acetic acid 
• 765302-46-3 ethyl (3-methoxy-4-{[(trifluoromethyl)sulfonyl]oxy}phenyl)acetate 
• 544-97-8 dimethyl zinc(II) 

Downstream Products

• 1292687-92-3 2-(3-(3-hydroxy-2,6-dimethylbenzyloxy)-4-methylphenyl)acetic acid 
• 1292688-15-3 ethyl 2-(3-(3-hydroxy-2,6-dimethylbenzyloxy)-4-methylphenyl)acetate 
• 1292688-13-1 ethyl 2-(3-(3-(tert-butyldimethylsilyloxy)-2,6-dimethylbenzyloxy)-4-methylphenyl)acetate 
• 1292687-94-5 3-((5-(carboxymethyl)-2-methylphenoxy)methyl)-2,4-dimethylphenyl sulfate 
• 1292687-96-7 2-(3-(3-methoxy-2,6-dimethylbenzyloxy)-4-methylphenyl)acetic acid 
• 1292688-19-7 ethyl 2-(3-(3-methoxy-2,6-dimethylbenzyloxy)-4-methylphenyl)acetate 
• 1200397-46-1 ethyl 2-(3-(2,6-dimethylbenzyloxy)-4-methylphenyl)acetate 
• 1200397-14-3 2-(3-(2,6-dimethylbenzyloxy)-4-methylphenyl)acetic acid 
• 765302-48-5 ethyl 2-(3-hydroxy-4-methylphenyl)acetate 

Relevant articles and documents

3-SUBSTITUTED COMPOUNDS FOR REDUCING URIC ACID

Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula 1. The uric acid-lowering effects of the compounds of this invention are used to treat or prevent a variety of conditions including g

Non-nucleoside reverse transcriptase inhibitors

The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R1-R5, R7a, R7b, R7c, R8-R10, X1, X2 m, n, o and p are as defined herein.

Non-nucleoside reverse transcriptase inhibitors

This invention relates to novel pyridazinone derivatives of formula I wherein R1-R4, R7, R8 and X1 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I, pharmaceutical compositions containing of formula I admixed with at least one solvent, carrier or excipient and processes to prepare compounds of formula I. The compounds are useful for treating disorders in which HIV and genetically related viruses are implicated